Literature DB >> 9827245

Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?

C G Dahlöf1, N Mathew.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827245     DOI: 10.1046/j.1468-2982.1998.1808539.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  13 in total

1.  No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.

Authors:  I Bouchelet; B Case; A Olivier; E Hamel
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.

Authors:  Peer Tfelt-Hansen; Kaj Seidelin; Michael Stepanavage; Christopher Lines
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

3.  Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries.

Authors:  Christopher M H Newman; Ian Starkey; Nigel Buller; Ricardo Seabra-Gomes; Simon Kirby; Jayasena Hettiarachchi; David Cumberland; William S Hillis
Journal:  Eur J Clin Pharmacol       Date:  2005-09-08       Impact factor: 2.953

Review 4.  Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review.

Authors:  S S Jhee; T Shiovitz; A W Crawford; N R Cutler
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 5.  Almotriptan: a review of its use in migraine.

Authors:  Susan J Keam; Karen L Goa; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.

Authors:  Pia Frisk; Sofia K Sporrong; Gunnar Ljunggren; Björn Wettermark; Mia von Euler
Journal:  Eur J Clin Pharmacol       Date:  2016-02-27       Impact factor: 2.953

7.  Open label study of intranasal sumatriptan (Imigran) for footballer's headache.

Authors:  P McCrory; J Heywood; A Ugoni
Journal:  Br J Sports Med       Date:  2005-08       Impact factor: 13.800

Review 8.  Tolerability of the triptans: clinical implications.

Authors:  Giuseppe Nappi; Giorgio Sandrini; Grazia Sances
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 9.  Over-the-counter triptans for migraine : what are the implications?

Authors:  Peer Tfelt-Hansen; Timothy J Steiner
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 10.  Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.